EBV-TCR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-TCR-T Cells, covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT [Phase 1]